Speechmatics, a privately owned UK-based software development company founded in 2006, employs approximately 170 people (as of 2023). The company's primary offering is Autonomous Speech Recognition technology.
On September 15, 2025, and September 16, 2025, Speechmatics launched a next-generation Medical Speech-to-Text (STT) model for clinical transcription. This model achieved 93% general real-world accuracy, exhibiting a 50% reduction in medical term errors compared to competitors. The model is designed for the speed and complexity of medical care, expanding coverage of medical and pharmaceutical terminology and optimizing for rapid, multi-speaker dialogue. A separate news story discussed the broader impact of AI in radiology, noting the use of ambient voice systems to capture findings and the role of radiologists in final authoring. This story did not directly involve Speechmatics' activities. Another news item mentioned a competitor, TwinMind, releasing a new speech-recognition model, Ear-3, but this was not directly related to Speechmatics' announcements.
Subscribe for full access to Speechmatics's products in full detail
Subscribe for full access to Speechmatics's revenue in full detail
Subscribe for full access to Speechmatics's products in full detail 
